Updates in Metastatic ER+ Breast Cancer

  • DCI APP lecture series is a once monthly 1 CME credit hour events directed toward advanced practice providers as well as pharmacists and registered nurses who care for all patients treated at Duke Cancer Institute.

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Pharmacists

Learning Objectives

  • Identifying changes in 1st line therapies for metastatic ER+ breast cancer
  • Understanding the evidence-based current role of ct DNA testing in metastatic ER+ breast cancer
  • Recognizing actionable mutations on next-generation sequencing
  • Identifying common side effects and laboratory changes expected with newly approved therapies for metastatic ER+ breast cancer

Course summary

Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 0.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
04/27/2026
Registration Expires: 
04/26/2028
Part of: 
DCI-Advanced Practice Provider Lecture Series 2026 Enduring
Rating: 
0
  • Dr. Katelyn Linker, DNP, AGNP-C
  • ACPE - Pharmacist
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • Attendance
  • JA Credit - AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 0.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.